Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip J Clements

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Rheumatology (Oxford, England)|March 24, 2010
Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three casesDinesh Khanna, Harsh Agrawal, Philip J Clements
Current Rheumatology Reports|May 16, 2007
Management of interstitial lung disease in systemic sclerosis: lessons from SLS and FASTNihal Fathi, Daniel E Furst, Philip J Clements
The Journal of Rheumatology|December 31, 2009
Antineutrophil cytoplasmic antibody-positive digital necrosis in a patient with limited systemic sclerosisMaida Wong, Veena K Ranganath, Philip J Clements
Rheumatic Diseases Clinics of North America|July 5, 2003
Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosisAntony T H Lin, Philip J Clements, Daniel E Furst
The Journal of Rheumatology|December 19, 2007
Does incorporation of aids and devices make a difference in the score of the health assessment questionnaire-disability index? Analysis from a scleroderma clinical trialDinesh Khanna, Philip J Clements, Arnold E Postlethwaite, et al.
Statistical Methods in Medical Research|March 7, 2007
Assessing disease progression using a composite endpointWeng Kee Wong, Daniel E Furst, Philip J Clements, et al.
Rheumatology (Oxford, England)|April 3, 2012
Articular involvement in systemic sclerosisJérôme Avouac, Philip J Clements, Dinesh Khanna, et al.
Seminars in Arthritis and Rheumatism|December 20, 2011
Arthritis in systemic sclerosis: systematic review of the literature and suggestions for the performance of future clinical trials in systemic sclerosis arthritisPhilip J Clements, Yannick Allanore, Dinesh Khanna, et al.
Current Rheumatology Reports|March 20, 2009
Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trialsKaren Au, Dinesh Khanna, Philip J Clements, et al.
Arthritis Care & Research|October 21, 2011
Work productivity in scleroderma: analysis from the University of California, Los Angeles scleroderma quality of life studyManjit K Singh, Philip J Clements, Daniel E Furst, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Rheumatology (Oxford, England)|March 24, 2010
Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three casesDinesh Khanna, Harsh Agrawal, Philip J Clements
Current Rheumatology Reports|May 16, 2007
Management of interstitial lung disease in systemic sclerosis: lessons from SLS and FASTNihal Fathi, Daniel E Furst, Philip J Clements
The Journal of Rheumatology|December 31, 2009
Antineutrophil cytoplasmic antibody-positive digital necrosis in a patient with limited systemic sclerosisMaida Wong, Veena K Ranganath, Philip J Clements
Rheumatic Diseases Clinics of North America|July 5, 2003
Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosisAntony T H Lin, Philip J Clements, Daniel E Furst
The Journal of Rheumatology|December 19, 2007
Does incorporation of aids and devices make a difference in the score of the health assessment questionnaire-disability index? Analysis from a scleroderma clinical trialDinesh Khanna, Philip J Clements, Arnold E Postlethwaite, et al.
Statistical Methods in Medical Research|March 7, 2007
Assessing disease progression using a composite endpointWeng Kee Wong, Daniel E Furst, Philip J Clements, et al.
Rheumatology (Oxford, England)|April 3, 2012
Articular involvement in systemic sclerosisJérôme Avouac, Philip J Clements, Dinesh Khanna, et al.
Seminars in Arthritis and Rheumatism|December 20, 2011
Arthritis in systemic sclerosis: systematic review of the literature and suggestions for the performance of future clinical trials in systemic sclerosis arthritisPhilip J Clements, Yannick Allanore, Dinesh Khanna, et al.
Current Rheumatology Reports|March 20, 2009
Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trialsKaren Au, Dinesh Khanna, Philip J Clements, et al.
Arthritis Care & Research|October 21, 2011
Work productivity in scleroderma: analysis from the University of California, Los Angeles scleroderma quality of life studyManjit K Singh, Philip J Clements, Daniel E Furst, et al.
Pageof 10